Operating margin moved 44 bp lower
Operating margin changed -44 basis points from the comparable as-filed period.
7.87%→7.43%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KSS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue decreased 0.9%
Revenue changed -0.9% from the comparable as-filed period.
$3.5B→$3.5B3 prior comparisons
Inventory / revenue moved 156 bp lower
Inventory / revenue changed -156 basis points from the comparable as-filed period.
84.43%→82.87%2 prior comparisons
Operating income decreased 6.5%
Operating income changed -6.5% from the comparable as-filed period.
$279.0M→$261.0M3 prior comparisons
Net income decreased 1.3%
Net income changed -1.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$153.0M→$151.0M3 prior comparisons
Inventory decreased 2.7%
Inventory changed -2.7% from the comparable as-filed period.
$3.0B→$2.9B3 prior comparisons
Selling, general & administrative decreased 0.9%
Selling, general & administrative changed -0.9% from the comparable as-filed period.
$1.2B→$1.2B3 prior comparisons
Operating income decreased 23.3%
Operating income changed -23.3% from the comparable as-filed period.
$60.0M→$46.0M3 prior comparisons
Operating cash flow increased 19.6%
Operating cash flow changed +19.6% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
-$92.0M→-$74.0M6 prior comparisons
Revenue decreased 2.0%
Revenue changed -2.0% from the comparable as-filed period.
$3.2B→$3.2B3 prior comparisons
Capital expenditure decreased 23.6%
Capital expenditure changed -23.6% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$110.0M→$84.0M6 prior comparisons
Operating margin moved 40 bp lower
Operating margin changed -40 basis points from the comparable as-filed period.
1.86%→1.45%3 prior comparisons
Capex / revenue moved 75 bp lower
Capex / revenue changed -75 basis points from the comparable as-filed period.
3.40%→2.65%2 prior comparisons
Net income increased 6.7%
Net income changed +6.7% from the comparable as-filed period.
-$15.0M→-$14.0M3 prior comparisons
Inventory decreased 7.7%
Inventory changed -7.7% from the comparable as-filed period.
$3.1B→$2.9B3 prior comparisons
SBC / revenue moved 1 bp higher
SBC / revenue changed +1 basis points from the comparable as-filed period.
0.28%→0.28%2 prior comparisons
Selling, general & administrative decreased 1.6%
Selling, general & administrative changed -1.6% from the comparable as-filed period.
$1.2B→$1.1B3 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
$9.0M→$9.0M6 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.